Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation

Mise à jour : Il y a 4 ans
Référence : NCT00143273

Femme Homme

Extrait

To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.


Critère d'inclusion

  • Osteoporosis

Liens